News & Updates

Clinicians may use liver stiffness measurement (LSM) by transient elastography (TE) to accurately predict decompensation and all-cause mortality in patients with compensated alcohol-related liver disease (ALD), suggests a study.

Combination treatment with 12 sessions of low-intensity shockwave therapy (LiST) three times weekly and daily tadalafil for 4 weeks results in a 2-point difference in the International Index of Erectile Function–Erectile Function domain (IIEF-EF) compared with sham therapy plus tadalafil in patients with severe vasculogenic erectile dysfunction (ED) after 1 and 3 months of treatment completion.

The phase III NOTUS trial further validates the potential of the monoclonal antibody dupilumab in reducing exacerbations and improving lung function and quality of life (QoL) in patients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation.

Statins are effective for primary prevention of cardiovascular disease (CVD) and all-cause mortality in individuals aged 75–84 and ≥85 years, and are not associated with significantly increased risks of myopathies and liver dysfunction, according to a target trial emulation conducted using real-world territory-wide electronic health records in Hong Kong.

According to a study conducted by the University of Hong Kong (HKU) and Queen Mary Hospital (QMH) since mid-2018, advanced imaging can identify patients with acute ischaemic stroke for intra-arterial thrombectomy even beyond 6 hours from symptom onset.

Erectile dysfunction (ED) is independently associated with a higher risk of major adverse cardiovascular events (MACE), suggests a study. Moreover, rural men appear to be at greater risk of MACE, with an even higher risk among those with an ED diagnosis.